Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

NCT03839771

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AU-Adelaide-FLINDERS Adelaide, Australia
  • AU-Adelaide-RAH Adelaide, Australia
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Camperdown-RPA Camperdown, Australia
View all 181 locations
View Trial Details
Active, Not Recruiting

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

NCT04756401

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • State University of New York Upstate Medical University Syracuse, New York, United States
  • UNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina, United States
View Trial Details
Active, Not Recruiting

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

NCT03789981

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AO Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy
  • IRCCS Casa sollievo sofferenza San Giovanni Rotondo, FOGGIA, Italy
  • IRCCS AOU S. Martino Genova Genova, GE, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.

NCT03541083

Conditions
ALL, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • BE-Antwerpen Edegem-UZA Antwerp, Belgium
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Brugge-AZBRUGGE Bruges, Belgium
  • BE-Gent-UZGENT Ghent, Belgium
View all 18 locations
View Trial Details
Active, Not Recruiting

Project Baseline Health Study

NCT03154346

Conditions
ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Baseline Study South San Francisco, California, United States
  • Stanford Medicine Stanford, California, United States
  • California Health and Longevity Institute Westlake Village, California, United States
  • Duke University School of Medicine Durham, North Carolina, United States
View Trial Details

Related conditions